Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析

【英語タイトル】Intellia Therapeutics Inc (NTLA) - Financial and Strategic SWOT Analysis Review

Single User(1名様閲覧用)USD300 ⇒換算¥31,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥63,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥95,400見積依頼/購入/質問フォーム

Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, inborn errors of metabolism and primary hyperoxaluria. It also develops ex vivo programs such as hematopoietic stem cells and chimeric antigen receptor T cells. Intellia Therapeutics conducts genome editing in the fields of immuno-oncology and autoimmune and inflammatory diseases. The company has partnership with various bioscience and pharmaceutical companies to develop its products. Intellia Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Intellia Therapeutics Inc Key Recent Developments

Feb 27,2019: Intellia Therapeutics announces fourth quarter and full-year 2018 financial results
Jan 24,2019: Intellia Therapeutics names Fred Cohen, M.D., to board of directors
Oct 31,2018: Intellia Therapeutics announces third quarter 2018 financial results and corporate developments
Oct 29,2018: Intellia Therapeutics appoints Glenn Goddard as new Chief Financial Officer
Oct 18,2018: Intellia Therapeutics presents new data in in vivo and ex vivo programs at the 26th Annual Congress of the European Society of Gene and Cell Therapy

This comprehensive SWOT profile of Intellia Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intellia Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Intellia Therapeutics Inc – Key Information
Intellia Therapeutics Inc – Overview
Intellia Therapeutics Inc – Key Employees
Intellia Therapeutics Inc – Key Employee Biographies
Intellia Therapeutics Inc – Key Operational Heads
Intellia Therapeutics Inc – Major Products and Services
Intellia Therapeutics Inc – History
Intellia Therapeutics Inc – Company Statement
Intellia Therapeutics Inc – Locations And Subsidiaries
Intellia Therapeutics Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Intellia Therapeutics Inc – Business Description
Intellia Therapeutics Inc – Corporate Strategy
Intellia Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Intellia Therapeutics Inc – Strengths
Intellia Therapeutics Inc – Weaknesses
Intellia Therapeutics Inc – Opportunities
Intellia Therapeutics Inc – Threats
Intellia Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Intellia Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Intellia Therapeutics Inc, Key Information
Intellia Therapeutics Inc, Key Ratios
Intellia Therapeutics Inc, Share Data
Intellia Therapeutics Inc, Major Products and Services
Intellia Therapeutics Inc, History
Intellia Therapeutics Inc, Key Employees
Intellia Therapeutics Inc, Key Employee Biographies
Intellia Therapeutics Inc, Key Operational Heads
Intellia Therapeutics Inc, Other Locations
Intellia Therapeutics Inc, Subsidiaries
Intellia Therapeutics Inc, Key Manufacturing facilities
Intellia Therapeutics Inc, Key Competitors
Intellia Therapeutics Inc, SWOT Analysis
Intellia Therapeutics Inc, Ratios based on current share price
Intellia Therapeutics Inc, Annual Ratios
Intellia Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Intellia Therapeutics Inc, Performance Chart
Intellia Therapeutics Inc, Ratio Charts

★調査レポート[Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析] (コード:DATA904C14923)販売に関する免責事項を必ずご確認ください。
★調査レポート[Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ